Home β€Ί Stock analysis β€Ί LEGN

Legend Biotech (LEGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

LEGN slides 6.7% to $18.48. Closed at $18.48, -6.67% vs the prior close of $19.80. Day range $18.40–$19.77, opened at $19.69.

Last close$18.48-6.67%
Day range18.40–19.77
Open19.69
Volume2.96M
52-week range16.24–37.50
Avg volume (20d)2.18M

LEGN daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” LEGN slides 6.7% to $18.48
Oct 15, 2026 β€” LEGN jumps 4.0% to $19.80, 3 up days in a row
Oct 14, 2026 β€” LEGN jumps 6.5% to $19.04
Oct 13, 2026 β€” LEGN rises 0.4% to $17.88
Oct 12, 2026 β€” LEGN slides 4.4% to $17.80, 3 down days in a row
Oct 9, 2026 β€” LEGN dips 0.5% to $18.62
Oct 8, 2026 β€” LEGN dips 2.1% to $18.71
Oct 7, 2026 β€” LEGN rises 2.1% to $19.12
Oct 6, 2026 β€” LEGN ends flat (-0.3%) to $18.72
Oct 5, 2026 β€” LEGN rises 1.1% to $18.77
Oct 2, 2026 β€” LEGN slides 3.9% to $18.57

LEGN latest news & SEC filings

Every SEC filing by or about LEGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006646

Oct 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006593

Oct 7, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001171843-26-006498

Oct 1, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001796536-26-000010

Sep 29, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001959173-26-007138

Sep 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0002088468-26-000006

Sep 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001814673-26-000005

Sep 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0002106809-26-000005

Sep 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0002068365-26-000009

Sep 25, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006229

Sep 24, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006215

Sep 15, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006050

Sep 14, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006027

Aug 18, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-005623

Aug 11, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001801198-26-000022

Things to know before you trade LEGN

LEGN market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202619.6919.7718.4018.482.96M
Oct 15, 202619.2519.9218.8519.801.57M
Oct 14, 202617.9419.7317.7519.043.53M
Oct 13, 202617.6118.2817.5617.882.46M
Oct 12, 202618.4018.4917.6917.802.63M
Oct 9, 202618.7819.0618.5518.621.39M
Oct 8, 202618.9118.9118.0918.712.15M
Oct 7, 202618.7319.2418.5819.121.57M
Oct 6, 202619.0019.2518.5518.721.35M
Oct 5, 202618.5018.8217.9218.771.76M
Oct 2, 202619.3519.6418.5218.572.53M
Oct 1, 202619.6119.7819.1919.322.22M
Sep 30, 202618.9020.0018.8519.892.96M
Sep 29, 202618.5019.2618.4618.821.97M
Sep 28, 202618.8018.8918.4018.621.71M
Sep 25, 202619.4919.6918.8519.111.43M
Sep 24, 202618.3019.1218.1519.061.78M
Sep 23, 202618.6219.0818.2718.452.41M
Sep 22, 202618.8518.8618.4118.642.31M
Sep 21, 202617.9518.6517.8118.532.83M

About Legend Biotech

Legend Biotech (LEGN) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in SOMERSET, NJ. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1801198.

LEGN board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Patrick John CaseyDirectorSep 28, 2026
Tomas J. HeymanDirectorSep 28, 2026
Ying HuangChief Executive OfficerJul 2, 2026
Darren Xiaohui JiDirectorSep 28, 2026
Gareth KungDirectorMar 18, 2026
Li MaoDirectorSep 28, 2026
Robin MengDirectorMar 18, 2026
Peter SaloveyDirectorSep 28, 2026
Corazon (Corsee) D. SandersDirectorSep 28, 2026
Ye WangDirectorMar 18, 2026
Fangliang ZhangDirectorMar 18, 2026

Executive officers

NameTitleLatest filing
Alan BashInterim CEOAug 18, 2026
Ying HuangChief Executive OfficerJul 2, 2026
Carlos E SantosChief Financial OfficerSep 23, 2026
Ingrid ZhangChief Executive OfficerSep 16, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 21, 2026Carlos E SantosSale5,430$9.14
Sep 21, 2026Carlos E SantosSale5,430$9.14
Sep 21, 2026Carlos E SantosSale5,430$9.14
Sep 21, 2026Carlos E SantosSale5,430$9.14
Jun 30, 2026Patrick John CaseySale6,000$14.80
Jun 30, 2026Patrick John CaseySale6,000$14.80
Jun 30, 2026Patrick John CaseySale6,000$14.80
Jun 30, 2026Patrick John CaseySale6,000$14.80
Jun 25, 2026Ying HuangSale5,566$14.78
Jun 25, 2026Ying HuangSale5,566$14.78
Jun 25, 2026Ying HuangSale5,566$14.78
Jun 25, 2026Ying HuangSale5,566$14.78
Mar 25, 2026Ying HuangSale9,936$8.77
Mar 25, 2026Ying HuangSale9,936$8.77
Mar 25, 2026Ying HuangSale9,936$8.77

LEGN financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

LEGN earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on LEGN

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.